People with multiple sclerosis have a higher risk of developing dementia than the general population, a meta-analysis reports ...

Life expectancy for those with secondary progressive multiple sclerosis may be a bit lower than for the larger population, but new treatments offer improvements.

Early signs of multiple sclerosis can include blurry vision, muscle weakness, dizziness and fatigue, and unusual tingling or pain sensations. These early warning signs occur because of damage to the ...

Background Mortality data from Europe and North America show a shorter life expectancy for people with multiple sclerosis (MS). It is not known if a similar mortality risk exists in the southern ...

Life expectancy in people with multiple sclerosis has improved over the last 50 years, writes columnist Leigh Anne Nelson.

The study examined if relationships between identity motives (self-esteem, efficacy, continuity, distinctiveness, belonging, and meaning), health-related quality of life, and depressive symptoms ...

Life expectancy for those with MS has increased over time thanks to treatment breakthroughs and improvements in MS treatments, better healthcare, and self-care strategies that anyone with multiple ...

Objective Survival and causes of death (COD) in multiple sclerosis (MS) provide ultimate endpoints. We aimed to investigate survival and COD in a 60-year population-based MS cohort compared with the ...

Median life expectancy after onset of multiple sclerosis is fourteen years for males and twenty years for females. Males, on an average, reach the bedridden stage of disability about eleven years ...

Ozanimod is an approved treatment for relapsing forms of multiple sclerosis (RMS) that has been shown to reduce relapses, new brain lesions, and brain volume loss relative to intramuscular interferon ...

Objectives In 2002, the UK's National Institute for Health and Care Excellence concluded that the multiple sclerosis (MS) disease modifying therapies; interferon-β and glatiramer acetate, were not ...